Sue Wallcraft is a member of the Audit and Risk Management Committee and the Remuneration Committee. Sue is an experienced general counsel and company secretary with over 25 years’ experience in the pharmaceutical industry and health charities. She is a qualified English solicitor and brings significant legal and governance knowledge to the board. Sue is currently General Counsel and Company Secretary for Vernalis (R&D) Limited, a non-executive director of Medicines Discovery Catapult.
Susan Wallcraft
Latest news
-
LifeArc backs major study of 80,000 blood samples to advance research into Parkinson’s, Alzheimer’s and rare dementias
-
Multimillion-pound partnership breaks down barriers in MND research
-
Could an existing antibiotic be used to treat rare liver disease?